Should you buy SBFM stock?
Last updated:
Based on market data through , StockInvest.us rates Sunshine Biopharma, Inc. (SBFM) as a Strong Sell Candidate with a technical score of -5.37 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Sell signal since
- Price since signal Up 4.27%
- 3-month trend forecast Down 76.37%
- Easy Tracking In The Watchlist
Sunshine Biopharma, Inc. stock price down 0.81% on Monday
(Market data through Aug 10, 2026)
The Sunshine Biopharma, Inc. stock price fell by -0.81% on the last day (Monday, 10th Aug 2026) from $1.23 to $1.22. During the last trading day the stock fluctuated 2.93% from a day low at $1.20 to a day high of $1.23. The price has fallen in 5 of the last 10 days and is down by -20.26% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -11 million shares and in total, 333 thousand shares were bought and sold for approximately $406.48 thousand.
The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $1.35 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
SBFM Signals & Forecast
A buy signal was issued from a pivot bottom point on Friday, July 31, 2026, and so far it has risen 4.27%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sunshine Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.26 and $1.77. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock
Sunshine Biopharma, Inc. finds support from accumulated volume at $1.17 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0350 between high and low, or 2.93%. For the last week the stock has had daily average volatility of 17.58%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (SBFM) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Sunshine Biopharma, Inc. to open at $1.22, and during the day (based on 14 day Average True Range), to move between $1.11 and $1.33, which gives a possible trading interval of +/-$0.221 (+/-19.88%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 19.88% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.23 (0.82%) than the support at $1.17 (4.10%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Sunshine Biopharma, Inc. stock A Buy?
Sunshine Biopharma, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Current score:
-5.368
Strong Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $1.22 ( 0.410%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
SBFM Performance
Trading levels for SBFM
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.25 | 2.46% |
| R2 | 1.24 | 1.36% |
| R1 | 1.23 | 0.686% |
| Price | 1.22 | |
| S1 | 1.20 | -1.51% |
| S2 | 1.19 | -2.18% |
| S3 | 1.18 | -3.28% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 1.33 | 9.02% |
| R2 | 1.31 | 7.38% |
| R1 | 1.23 | 0.82% |
| Price | 1.22 | |
| S1 | 1.17 | -4.10% |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Sunshine Biopharma, Inc. Stock.
Buy SBFM